Denes Zadori
Denes Zadori
associate professor in neurology, Department of Neurology, University of Szeged
Verified email at
TitleCited byYear
Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells
Z Datki, A Juhász, M Gálfi, K Soós, R Papp, D Zádori, B Penke
Brain research bulletin 62 (3), 223-229, 2003
Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease
D Zádori, A Geisz, E Vámos, L Vécsei, P Klivényi
Pharmacology Biochemistry and Behavior 94 (1), 148-153, 2009
Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies
D Zádori, P Klivényi, E Vámos, F Fülöp, J Toldi, L Vécsei
Journal of neural transmission 116 (11), 1403-1409, 2009
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington’s disease
D Zádori, G Nyiri, A Szőnyi, I Szatmári, F Fülöp, J Toldi, TF Freund, ...
Journal of neural transmission 118 (6), 865-875, 2011
Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders
D Zádori, P Klivényi, L Szalárdy, F Fülöp, J Toldi, L Vécsei
Journal of the neurological sciences 322 (1-2), 187-191, 2012
In vitro model of neurotoxicity of Aβ 1–42 and neuroprotection by a pentapeptide: irreversible events during the first hour
Z Datki, R Papp, D Zádori, K Soós, L Fülöp, A Juhász, G Laskay, ...
Neurobiology of disease 17 (3), 507-515, 2004
Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets
D Zadori, G Veres, L Szalardy, P Klivenyi, J Toldi, L Vecsei
Journal of Alzheimer's Disease 42 (s3), S177-S187, 2014
Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects
L Szalárdy, P Klivényi, D Zádori, F Fulop, J Toldi, L Vécsei
Current medicinal chemistry 19 (13), 1899-1920, 2012
Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives
F Fulop, I Szatmari, E Vamos, D Zadori, J Toldi, L Vécsei
Current medicinal chemistry 16 (36), 4828-4842, 2009
Gray matter is targeted in first-attack multiple sclerosis
SE Schutzer, TE Angel, T Liu, AA Schepmoes, F Xie, J Bergquist, L Vécsei, ...
PloS one 8 (9), 2013
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity
L Szalardy, D Zadori, M Simu, K Bencsik, L Vecsei, P Klivenyi
Journal of the neurological sciences 331 (1-2), 38-42, 2013
Manipulating kynurenic acid levels in the brain–on the edge between neuroprotection and cognitive dysfunction
L Szalardy, D Zadori, J Toldi, F Fulop, P Klivenyi, L Vecsei
Current topics in medicinal chemistry 12 (16), 1797-1806, 2012
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
D Zádori, P Klivényi, I Plangár, J Toldi, L Vécsei
Journal of cellular and molecular medicine 15 (4), 701-717, 2011
Kynurenines in Parkinson’s disease: therapeutic perspectives
D Zádori, P Klivényi, J Toldi, F Fülöp, L Vécsei
Journal of neural transmission 119 (2), 275-283, 2012
Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy
I Plangár, D Zádori, P Klivényi, J Toldi, L Vécsei
Journal of Alzheimer's Disease 24 (s2), 199-209, 2011
Alzheimer’s disease: recent concepts on the relation of mitochondrial disturbances, excitotoxicity, neuroinflammation, and kynurenines
D Zádori, G Veres, L Szalárdy, P Klivényi, L Vécsei
Journal of Alzheimer's Disease 62 (2), 523-547, 2018
Electron transport disturbances and neurodegeneration: From albert Szent-Györgyi’s concept (Szeged) till novel approaches to boost mitochondrial bioenergetics
L Szalárdy, D Zádori, P Klivényi, J Toldi, L Vécsei
Oxidative medicine and cellular longevity 2015, 2015
Synthesis and biological effects of some kynurenic acid analogs
K Nagy, I Plangár, B Tuka, L Gellért, D Varga, I Demeter, T Farkas, Z Kis, ...
Bioorganic & medicinal chemistry 19 (24), 7590-7596, 2011
Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ (1-42) and NAC treatment
Á Hunya, I Földi, V Szegedi, K Soós, M Zarándi, A Szabó, D Zádori, ...
Brain research bulletin 75 (5), 648-654, 2008
Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical …
A Fejes-Szabó, Z Bohár, E Vámos, G Nagy-Grócz, L Tar, G Veres, ...
Journal of Neural Transmission 121 (7), 725-738, 2014
The system can't perform the operation now. Try again later.
Articles 1–20